Kirikoshi, Hiroyuki

Publishing since 2001 (Junior)

Has published 92 publications in 10 years

Number of publications published per year by Kirikoshi, Hiroyuki. (Source : PubMed)

Distribution of publications types for Kirikoshi, Hiroyuki. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Yoneda M, Nozaki Y, Endo H, Mawatari H, Iida H, Fujita K, Yoneda K, Takahashi H, Kirikoshi H, Inamori M, Kobayashi N, Kubota K, Saito S, Maeyama S, Hotta K, Nakajima A. Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.  Dig. Dis. Sci.  2010;55;3  
•  Fujita K, Nozaki Y, Yoneda M, Wada K, Takahashi H, Kirikoshi H, Inamori M, Saito S, Iwasaki T, Terauchi Y, Maeyama S, Nakajima A. Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model.  Alcohol. Clin. Exp. Res.  2010;34 Suppl 1  
•  Mawatari H, Yoneda M, Fujita K, Nozaki Y, Shinohara Y, Sasaki H, Iida H, Takahashi H, Inamori M, Abe Y, Kobayashi N, Kubota K, Kirikoshi H, Nakajima A, Saito S. Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b.  J. Viral Hepat.  2010  
•  Suzuki K, Takahashi H, Abe Y, Inamori M, Watanabe S, Koide T, Tokoro C, Iida H, Hosono K, Endo H, Shimamura T, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Ono H, Akiyama H, Yazawa T, Nakajima A. A case of a peculiarly shaped gastrointestinal stromal tumor.  Endoscopy  2010;42 Suppl 2  
•  Kubota K, Wada T, Kato S, Mozaki Y, Yoneda M, Fujita K, Takahashi H, Inamori M, Abe Y, Kobayashi N, Kirikoshi H, Saito S, Inayama Y, Nakajima A. Highly active state of autoimmune pancreatitis with mikulicz disease.  Pancreas  2010;39;1  
•  Yoneda M, Hotta K, Nozaki Y, Endo H, Tomeno W, Watanabe S, Hosono K, Mawatari H, Iida H, Fujita K, Takahashi H, Kirikoshi H, Kobayashi N, Inamori M, Kubota K, Shimamura T, Saito S, Maeyama S, Wada K, Nakajima A. Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease.  Hepatol. Res.  2009;39;10  
•  Mawatari H, Inamori M, Fujita K, Yoneda M, Iida H, Endo H, Hosono K, Nozaki Y, Yoneda K, Akiyama T, Takahashi H, Goto A, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Nakajima A. The continuous real-time 13C-octanoate breath test for patients with nonalcoholic steatohepatitis using the BreathID system.  Hepatogastroenterology  2009;56;94-95  
•  Fujita K, Nozaki Y, Wada K, Yoneda M, Fujimoto Y, Fujitake M, Endo H, Takahashi H, Inamori M, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Nakajima A. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis.  Hepatology  2009;50;3  
•  Nozaki Y, Fujita K, Yoneda M, Wada K, Shinohara Y, Takahashi H, Kirikoshi H, Inamori M, Kubota K, Saito S, Mizoue T, Masaki N, Nagashima Y, Terauchi Y, Nakajima A. Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease.  J. Hepatol.  2009;51;3  
•  Mawatari H, Yoneda M, Fujita K, Nozaki Y, Shinohara Y, Sasaki H, Iida H, Takahashi H, Inamori M, Abe Y, Kobayashi N, Kubota K, Kirikoshi H, Nakajima A, Saito S. Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b.  J. Viral Hepat.  2009  

[ See timeline ] [ See all publications ]